The Valley Desk

NCT02727699 · Interventional trial

A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu)

Overall registry status Completed

Phase 2

Conditions Dementia, Alzheimer Type

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov